These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16678831)

  • 21. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference.
    Onat A; Hergenç G; Yüksel H; Can G; Ayhan E; Kaya Z; Dursunoğlu D
    Clin Nutr; 2009 Feb; 28(1):46-51. PubMed ID: 19010573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
    Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
    Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
    Onat A; Can G; Hergenç G; Uğur M; Yüksel H
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
    Ferrannini E; Balkau B; Coppack SW; Dekker JM; Mari A; Nolan J; Walker M; Natali A; Beck-Nielsen H;
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2885-92. PubMed ID: 17504904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal and total adiposity and risk of coronary heart disease in men.
    Rexrode KM; Buring JE; Manson JE
    Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1047-56. PubMed ID: 11443505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?
    Bo S; Gambino R; Uberti B; Mangiameli MP; Colosso G; Repetti E; Gentile L; Cassader M; Pagano GF
    Eur J Clin Invest; 2005 Apr; 35(4):265-70. PubMed ID: 15816996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians.
    Forouhi NG; Sattar N; McKeigue PM
    Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1327-31. PubMed ID: 11571595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk.
    Onat A; Can G; Örnek E; Sansoy V; Aydın M; Yüksel H
    Eur J Clin Invest; 2013 Nov; 43(11):1129-39. PubMed ID: 24020867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
    Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
    Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study.
    Gruson E; Montaye M; Kee F; Wagner A; Bingham A; Ruidavets JB; Haas B; Evans A; Ferrières J; Ducimetière PP; Amouyel P; Dallongeville J
    Heart; 2010 Jan; 96(2):136-40. PubMed ID: 19561364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and C-reactive protein among cardiology patients.
    Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
    Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.